These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 8702226

  • 41. The therapeutic activity in cancer of IL-2 in combination with other cytokines.
    Truitt GA, Brunda MJ, Levitt D, Anderson TD, Sherman MI.
    Cancer Surv; 1989; 8(4):875-89. PubMed ID: 2701733
    [Abstract] [Full Text] [Related]

  • 42. [Interleukin-2 based immunotherapy of cancer].
    Geertsen PF, Hermann GG, Claësson MH, Steven K, Zeuthen J, von der Maase H.
    Ugeskr Laeger; 1990 Nov 19; 152(47):3513-7. PubMed ID: 2256204
    [Abstract] [Full Text] [Related]

  • 43. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
    Fukuhara H, Matsumoto A, Kitamura T, Takeuchi T.
    BJU Int; 2006 Jun 19; 97(6):1314-21. PubMed ID: 16686731
    [Abstract] [Full Text] [Related]

  • 44. Tumour burden and interleukin-2 dose affect the interaction between low-dose total body irradiation and interleukin 2.
    Safwat A, Aggerholm N, Roitt I, Overgaard J, Hokland M.
    Eur J Cancer; 2004 Jun 19; 40(9):1412-7. PubMed ID: 15177501
    [Abstract] [Full Text] [Related]

  • 45. The induction of in vivo proliferation of long-lived CD44hi CD8+ T cells after the injection of tumor cells expressing IFN-alpha1 into syngeneic mice.
    Belardelli F, Ferrantini M, Santini SM, Baccarini S, Proietti E, Colombo MP, Sprent J, Tough DF.
    Cancer Res; 1998 Dec 15; 58(24):5795-802. PubMed ID: 9865738
    [Abstract] [Full Text] [Related]

  • 46. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy.
    Berhanu A, Huang J, Alber SM, Watkins SC, Storkus WJ.
    Cancer Res; 2006 May 01; 66(9):4895-903. PubMed ID: 16651446
    [Abstract] [Full Text] [Related]

  • 47. Cotransduction of CCL27 gene can improve the efficacy and safety of IL-12 gene therapy for cancer.
    Gao JQ, Kanagawa N, Motomura Y, Yanagawa T, Sugita T, Hatanaka Y, Tani Y, Mizuguchi H, Tsutsumi Y, Mayumi T, Okada N, Nakagawa S.
    Gene Ther; 2007 Mar 01; 14(6):491-502. PubMed ID: 17203106
    [Abstract] [Full Text] [Related]

  • 48. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
    Zou J, Rudwaleit M, Brandt J, Thiel A, Braun J, Sieper J.
    Arthritis Rheum; 2003 Mar 01; 48(3):780-90. PubMed ID: 12632433
    [Abstract] [Full Text] [Related]

  • 49. Inhibition of peritoneal metastasis in an animal gastric cancer model by interferon-gamma and interleukin-2.
    Okamoto T, Tsuburaya A, Yanoma S, Yoshikawa T, Cho H, Takanashi Y, Noguchi Y.
    Anticancer Res; 2003 Mar 01; 23(1A):149-53. PubMed ID: 12680206
    [Abstract] [Full Text] [Related]

  • 50. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid.
    Elsässer-Beile U, Kölble N, Grussenmeyer T, Wetterauer U, Schultze-Seemann W.
    Anticancer Res; 1998 Mar 01; 18(3B):1883-90. PubMed ID: 9677439
    [Abstract] [Full Text] [Related]

  • 51. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K, Kontani K, Ozaki Y, Sawai S, Tezuka N, Nagata T, Fujino S, Itoh Y, Taguchi O, Koide Y, Asai T, Ohkubo I, Ogasawara K.
    Cancer Res; 2003 Nov 15; 63(22):7920-5. PubMed ID: 14633722
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B, Akça D, Jung T, Muller GA, Reuss-Borst MA.
    J Rheumatol; 2000 May 15; 27(5):1128-35. PubMed ID: 10813277
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [The effects of IFN-gamma on the antitumor abilities of immunocytes and chemotherapeutic agents].
    Gu Q, Zhu Z, Yin H.
    Zhonghua Wai Ke Za Zhi; 1997 Feb 15; 35(2):89-91. PubMed ID: 10374484
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.